nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A systematic review on [18F]FLT-PET uptake as a measure of treatment response in cancer patients
|
Bollineni, V.R. |
|
2016 |
55 |
C |
p. 81-97 17 p. |
artikel |
2 |
Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: A meta-analysis
|
Yoon, Sang-Hee |
|
2016 |
55 |
C |
p. 38-46 9 p. |
artikel |
3 |
Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma
|
Veal, Gareth J. |
|
2016 |
55 |
C |
p. 56-64 9 p. |
artikel |
4 |
Diffuse large B-cell lymphoma with MYC gene rearrangements
|
de Jonge, A.V. |
|
2016 |
55 |
C |
p. 140-146 7 p. |
artikel |
5 |
Disparities in melanoma incidence and mortality in South-Eastern Europe: Increasing incidence and divergent mortality patterns. Is progress around the corner?
|
Barbaric, Jelena |
|
2016 |
55 |
C |
p. 47-55 9 p. |
artikel |
6 |
Dosing to rash? – The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash
|
Steffens, Michael |
|
2016 |
55 |
C |
p. 131-139 9 p. |
artikel |
7 |
Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer
|
Cresti, Nicola |
|
2016 |
55 |
C |
p. 27-37 11 p. |
artikel |
8 |
Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB–III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity
|
Eggermont, Alexander M.M. |
|
2016 |
55 |
C |
p. 111-121 11 p. |
artikel |
9 |
Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours
|
Rowland, Andrew |
|
2016 |
55 |
C |
p. 122-130 9 p. |
artikel |
10 |
Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data
|
Giefing, M. |
|
2016 |
55 |
C |
p. 147-157 11 p. |
artikel |
11 |
Ovarian cancer in Lynch syndrome; a systematic review
|
Helder-Woolderink, J.M. |
|
2016 |
55 |
C |
p. 65-73 9 p. |
artikel |
12 |
p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib
|
Krayem, Mohammad |
|
2016 |
55 |
C |
p. 98-110 13 p. |
artikel |
13 |
Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy
|
Tokito, Takaaki |
|
2016 |
55 |
C |
p. 7-14 8 p. |
artikel |
14 |
‘Tablet burden’ in patients with metastatic breast cancer
|
Milic, Marina |
|
2016 |
55 |
C |
p. 1-6 6 p. |
artikel |
15 |
The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04)
|
McLachlan, Sue-Anne |
|
2016 |
55 |
C |
p. 15-26 12 p. |
artikel |
16 |
Ultrasound surveillance for radiation-induced thyroid carcinoma in adult survivors of childhood cancer
|
Brignardello, Enrico |
|
2016 |
55 |
C |
p. 74-80 7 p. |
artikel |